Airway diseases
Interstitial lung diseases
Pulmonary vascular diseases
Symposium
New insights into quality control of lung function testing
Clinical
Aims : to describe the impact and relevance of quality control in pulmonary laboratories for continual improvement and quality assuranceto present the 1) re-examination of biological control in spirometry, 2) how to implement quality control in line with the DLCO/DLNO guidelines issued in 2017, 3) quality control standards in cardiopulmonary exercise testing and 4) data management in quality control programmes.
Target audience :
Clinical researcher, Lung function technologist, Nurse, Physiologist, Adult pulmonologist/Clinician
Methods :
Physiology, Pulmonary function testing
08:30
What’s new in spirometry biological quality control
B. Thompson(Parkville, Australia)
COI
-
Description
1
235
08:55
Updated ATS/ERS Technical Standard on spirometry
B. Graham(Saskatoon (SK), Canada)
COI
2
236
09:20
How to remain in line with the new DLCO/DLNO guidelines
A. Kendrick(Bristol (Avon), United Kingdom)
COI
-
Description
3
237
09:45
Cardiopulmonary exercise testing: can you trust the data
M. Johnson(Clydebank, United Kingdom)
COI
-
Description
4
238
10:10
Recent advances in data management
J. Blonshine(Mason, United States)
COI
-
Description
5
239
. . .
